Betamethasone Dipropionate

Overview

Betamethasone Dipropionate is a potent synthetic glucocorticoid steroid with anti-inflammatory and immunosuppressant properties. It is commonly used in the treatment of skin conditions such as eczema, psoriasis, and dermatitis.

API suppliers (14)

Suppliers of Betamethasone Dipropionate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• TAPI NL BVNetherlands1 active DMF
• SYMBIOTEC PHARMALAB PRIVATE LTDIndia1 active DMF GMP on record
• SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysia1 active DMF
• TIANJIN TIANYAO PHARMACEUTICALS CO LTDChina1 active DMF
• HENAN LIHUA PHARMACEUTICAL CO LTD1 active DMF
• CURIA SPAIN SAUSpain1 active DMF GMP on record
• HALCYON LABS PRIVATE LTDIndia1 active DMF
• Taro Pharmaceutical Industries Ltd.Israel1 active DMF GMP on record
• FARMABIOS SPAItaly1 active DMF
• COMPANIA ESPANOLA DE SINTESIS QUIMICA SA
• PHARMACIA AND UPJOHN SUB PFIZER INC
• QUATRUM
• HOECHST MARION ROUSSEL SA
• MAHIMA LIFE SCIENCES PRIVATE LTDIndia

EU CEP holders (5)

Companies holding a valid EU Certificate of Suitability (CEP) for Betamethasone Dipropionate, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Patent & exclusivity (US)

Per the FDA Orange Book (28 approved US products), the latest listed US patent on Betamethasone Dipropionate expires 19 Nov 2045. Generic API sourcing typically opens up once these lapse.

Therapeutic areas